index  
coursenewsroomcompanycontactlogin
 
 
  Mid & HindFoot Solutions
    Product Details
    Indications for Use/Contraindications
 
      Pre-Operative Planning
      Calcaneal Reconstruction
      Calcanea® Plate Positioning
      Calcanea® Plate Fixation using Locking Screws
      Calcanea® Plate Fixation using Variable Angle Screws
      Post-Operative Care
 

Calcanea® - Surgical Technique
Previous | Next Next

Calcaneal fractures are usually caused by a high-velocity impact to the heel. The most common mechanism of injury is a fall from a height of 2 meters or more, but calcaneal fractures also result from motor vehicle accidents.

Calcaneal fractures may be extra or intra-articular. Surgical treatment with open reduction and internal fixation (ORIF) is now well accepted to be the method which gives recognized clinical results, especially for type II and type III calcaneal fractures according to the Sanders classification. The aim of the surgical procedure is to restore the articular surface of the calcaneus and to obtain an anatomic reconstruction (height and width of the calcaneus).

However, clinical and technical problems can occur due to the thickness and the stiffness of the plates, in particular superficial necrosis of the surgical wounds and peroneal tendonitis. These problems are related to the traction onto the skin flap during surgery and to the thickness of the plates that may cause ischemic problems to the skin and impingement of the peroneal tendons.

Moreover, most plates have a limited number of holes and do not allow for significant molding because of their thickness. In this situation, the screws have to be inserted in predetermined sites of the calcaneal wall, and especially in the fractured zones of the lateral calcaneal wall, in the comminuted fractures. Sometimes this can lead to insufficient grip of the screws and therefore insufficient mechanical resistance of the implant. In those circumstances, early movement to prevent joint stiffness and enhance fractured soft tissue healing is not possible.

The CALCANEA® plate is the solution of choice for the ORIF treatment of calcaneal fractures.

This plate is made of titanium alloy (TA16V4), has an anatomical shape corresponding to the anatomy of the calcaneus. It is available in three different sizes, to better fit the calcaneus shape (5.5 cm long for size small, 6.5 cm long for size medium and 7.5 cm long for size large). Its thickness is 1 mm in the middle, and 1.80 mm in the sites of main fixation. 3-4 holes are present in its anterior, posterior and upper parts for fixation screws with threaded heads, and 9-10 holes for variable orientation of the screws. The plate is fixed using 3.5 mm screws. Holes in the plate provide fixation with up to 4 screws in the posterior tuberosity, 3 screws in the anterior process, and 7 screws in the middle. The limited thickness permits to mould the plate and to eventually cut it if the plate is overstuffing anatomically the calcaneus. The upper part of the posterior and anterior borders can sometimes be cut off, or bent for a dorso-plantar screw fixation. Before the definitive fixation of the plate, autologous or synthetic bone grafts may be inserted, if necessary, in the os trigonum of the calcaneus.

Advantages:

  • Increased stability by locking screw fixation and "bridging" of the primary fracture line
  • Low profile plate
  • Thickness allows remodeling according to the lateral wall of the calcaneus
  • Low irritation of soft tissues and tendons
  • Reconstruction of height and width of the calcaneus
  • Large number of holes for versatile fixation
  • Dual screw fixation system (locking & variable) allowing stable fixation regardless of bone conditions
  • Angulation of the screws up to 30°
  • Bi-cortical or mono-cortical fixation
  • Color-coded for the plate and the screws
 
Previous | Next Next

© Copyright 2005 - 2007 Integra LifeSciences Corporation. All Rights Reserved.
Newdeal® is a registered trademark of Newdeal, an Integra LifeSciences Corporation.
Integra Wave Logo is a trademark of Integra LifeSciences Corporation.

Terms of Use • Privacy Policy